Literature DB >> 23601794

Current smoking rate in patients with psychiatric disorders in Japan: questionnaire survey.

Wakako Umene-Nakano1, Reiji Yoshimura, Tsutomu Hoshuyama, Chiharu Yoshii, Kenji Hayashi, Hideki Nakano, Hikaru Hori, Atsuko Ikenouchi-Sugita, Asuka Katsuki, Kiyokazu Atake, Jun Nakamura.   

Abstract

The association between smoking and psychiatric disorders (PD) has been known for many years. Support for smoking cessation among patients with PD is provided in advanced nations, but there is a little support for smoking cessation among patients with PD in Japan, where few studies have investigated the smoking rate. The aim of the present study is to determine the smoking rate and smoking habits of Japanese patients with PD. The subjects included outpatients who visited the outpatient psychiatric clinic at a University hospital between January and March of 2011. They answered a questionnaire consisting of questions about their sociodemographic background and smoking habits. In an analysis of 733 subjects, the overall smoking rate was 25.1%. The smoking rates among the patients with schizophrenia and depression were 17.3% and 23.9%, respectively, and these rates were lower than the results of previous studies. Among the current smokers, 43.4% had experienced smoking cessation, and only 26.1% were not interested in smoking cessation. Of the current smokers, 37.5% spent between US$128.88 and US$257 per month on cigarettes.
© 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Psychiatric disorders; Schizophrenia; Smoking; Survey

Mesh:

Year:  2013        PMID: 23601794     DOI: 10.1016/j.psychres.2013.03.024

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  1 in total

1.  Gender differences and risk factors for smoking among patients with various psychiatric disorders in Saudi Arabia: a cross-sectional study.

Authors:  Fahad D Alosaimi; Mohammed Abalhassan; Bandar Alhaddad; Ebtihaj O Fallata; Abdulhadi Alhabbad; Rabab Alshenqiti; Mohammed Z Alassiry
Journal:  Int J Ment Health Syst       Date:  2018-05-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.